Improved migraine management in primary care: Results of a patient treatment experience study using zolmitriptan orally disintegrating tablet

International Journal of Clinical Practice

Volumn 60, Issue 12, 2006, Pages 1530-1535

  Shapero, G ^a   Dowson, A ^b   Lacoste, J P ^c   Almqvist, P ^d  

^a Markham Headache and Pain Treatment Centre   (Canada)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

Migraine; Primary care; Zolmitriptan orally disintegrating tablet; Zomig Appropriate for Primary care

Indexed keywords

ANALGESIC AGENT; ANTIEMETIC AGENT; ERGOT DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; TRIPTAN DERIVATIVE; ZOLMITRIPTAN;

ADULT; ARTICLE; CLINICAL DECISION MAKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; OPEN STUDY; OUTCOME VARIABLE; PATIENT ATTITUDE; PATIENT CARE; PHYSICIAN; PRIMARY CARE PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; TABLET; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; OXAZOLIDINONES; PATIENT SATISFACTION; SEROTONIN AGONISTS; TABLETS; TREATMENT OUTCOME; TRYPTAMINES;

EID: 33750975060     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01208.x     Document Type: Article

References (16)

1. Dowson AJ, Shapero G, Baos V et al. Primary care needs assessment for guidance on headache management. Headache Care 2005; 2: 43-6.
2. Kern R, Shapero G, Boudreau G et al. There is a strong unmet need for improved headache education among primary care physicians: Results from a primary care needs assessment. Headache Care 2005; 2: 47-9.
3. International Headache Society. Headache classification subcommittee. Cephalalgia 1988; 8 (Suppl. 7): S1-96.
4. Lipton RB, Diamond S, Reed M et al. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001; 41: 638-45.
5. MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: The global Migraine and Zolmitriptan Evaluation survey. Headache 2003; 43: 19-26.
6. Edmeads J, Lainez JM, Brandes JL et al. Potential of the Migraine Disability Assessment (MIDAS) Questionnaire as a public health initiative and in clinical practice. Neurology 2001; 56 (6 Suppl. 1): S29-34.
7. MacGregor EA, Brandes J, Gendolla A, Giammarco R. Migraine treatment strategies: The global Migraine And Zolmitriptan Evaluation (MAZE) survey - phase IV. Curr Med Res Opin 2004; 20: 1777-83.
8. Gawel MJ, Worthington I, Maggisano A. Systematic review of the use of triptans in acute migraine. Can J Neurol Sci 2001; 28: 30-41.
9. Gibbs TS, Fleischer AB Jr, Feldman SR et al. Health care utilization in patients with migraine: Demographics and patterns of care in the ambulatory setting. Headache 2003; 43: 330-5.
10. MacGregor EA. The doctor and the migraine patient: Improving compliance. Neurology 1997; 48 (Suppl. 3): S16-20.
11. Dowson AJ, Tepper SJ, Dahlöf C. Patients' preference for triptans and other medications as a tool for assessing the efficacy of acute treatments for migraine. J Headache Pain 2005; 6: 112-20.
12. Tfelt-Hansen P, Block G, Dahlöf C et al. International Headache Society clinical trials subcommittee. Guidelines for controlled trials of drugs in migraine: Second edition. Cephalalgia 2000; 20: 765-86.
13. Almqvist P, Brandreth T. ZAP primary care programme: Headache education through clinical experience. Headache Care 2005; 2: 239-42.
14. Dowson AJ, MacGregor EA, Purdy RA et al. Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine. Cephalalgia 2002; 22: 101-6.
15. Spierings ELH, Rapoport AM, Dodick DW, Charlesworth B. Acute treatment of migraine with zolmitriptan 5mg orally disintegrating tablet. CNS Drugs 2004; 18: 1133-41.
16. Loder EW, Dowson AJ, Spierings EL. Part II: Clinical efficacy and tolerability of zolmitriptan orally disintegrating tablet in the acute treatment of migraine. Curr Med Res Opin 2005; 21 (Suppl. 3): S8-12.